Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.7 | snail family zinc finger 1 |
Zeb1
|
ENSMUSG00000024238.7 | zinc finger E-box binding homeobox 1 |
Snai2
|
ENSMUSG00000022676.6 | snail family zinc finger 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_167539777_167540513 | Snai1 | 1950 | 0.216321 | -0.32 | 1.4e-02 | Click! |
chr2_167540595_167541629 | Snai1 | 2917 | 0.163130 | -0.28 | 2.7e-02 | Click! |
chr2_167542817_167543436 | Snai1 | 4931 | 0.131348 | -0.26 | 4.9e-02 | Click! |
chr2_167542309_167542460 | Snai1 | 4189 | 0.138322 | -0.25 | 5.5e-02 | Click! |
chr2_167541876_167542064 | Snai1 | 3775 | 0.143919 | -0.22 | 9.8e-02 | Click! |
chr16_14705282_14705734 | Snai2 | 344 | 0.913485 | -0.46 | 2.3e-04 | Click! |
chr16_14707769_14707934 | Snai2 | 1999 | 0.404008 | -0.37 | 4.0e-03 | Click! |
chr16_14706735_14707615 | Snai2 | 1323 | 0.531007 | -0.36 | 4.6e-03 | Click! |
chr16_14708705_14709220 | Snai2 | 3110 | 0.318329 | -0.33 | 1.0e-02 | Click! |
chr16_14705845_14706609 | Snai2 | 375 | 0.901484 | -0.29 | 2.3e-02 | Click! |
chr18_5696067_5696247 | Zeb1 | 34924 | 0.170191 | -0.31 | 1.7e-02 | Click! |
chr18_5758891_5759042 | Zeb1 | 27885 | 0.219883 | 0.28 | 3.2e-02 | Click! |
chr18_5603232_5604403 | Zeb1 | 73 | 0.958439 | -0.26 | 4.5e-02 | Click! |
chr18_5594842_5595315 | Zeb1 | 875 | 0.423293 | 0.26 | 4.8e-02 | Click! |
chr18_5592506_5593346 | Zeb1 | 382 | 0.529762 | 0.16 | 2.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_25264308_25268001 | 16.95 |
Tprn |
taperin |
1410 |
0.14 |
chr8_41052368_41053980 | 15.38 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr1_177446374_177448525 | 13.92 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr13_83716978_83717166 | 13.28 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
4309 |
0.15 |
chr3_88208985_88210116 | 12.52 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr15_76519928_76521866 | 11.37 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr5_131614206_131615000 | 11.16 |
2810432F15Rik |
RIKEN cDNA 2810432F15 gene |
835 |
0.43 |
chr2_178141581_178143125 | 11.00 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr2_172040251_172043672 | 10.49 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr15_76124987_76126454 | 10.36 |
BC024139 |
cDNA sequence BC024139 |
351 |
0.73 |
chr8_70119024_70120981 | 9.84 |
Ncan |
neurocan |
871 |
0.35 |
chr9_106147912_106149765 | 9.74 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr10_80300884_80302968 | 9.70 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr8_125897868_125898882 | 9.60 |
Pcnx2 |
pecanex homolog 2 |
58 |
0.88 |
chr6_37297951_37298469 | 8.91 |
Dgki |
diacylglycerol kinase, iota |
1427 |
0.53 |
chr6_114282516_114283979 | 8.76 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr7_87584098_87584781 | 8.52 |
Grm5 |
glutamate receptor, metabotropic 5 |
41 |
0.99 |
chr1_42703141_42704653 | 8.42 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr6_114130915_114132167 | 8.36 |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
122 |
0.97 |
chr3_34560367_34561122 | 8.34 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
352 |
0.85 |
chr3_94478073_94479450 | 8.29 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr8_94995811_94996872 | 8.12 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr8_70533499_70533650 | 8.05 |
Fkbp8 |
FK506 binding protein 8 |
543 |
0.56 |
chr14_65423052_65425451 | 8.01 |
Pnoc |
prepronociceptin |
909 |
0.6 |
chr3_94479508_94480443 | 7.96 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
366 |
0.63 |
chr7_78885666_78887958 | 7.95 |
Mir7-2 |
microRNA 7-2 |
1465 |
0.28 |
chr7_19005590_19007911 | 7.89 |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
2706 |
0.11 |
chr3_31309226_31310664 | 7.86 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr10_73096427_73097649 | 7.86 |
Pcdh15 |
protocadherin 15 |
2304 |
0.33 |
chr1_138839332_138840406 | 7.82 |
Lhx9 |
LIM homeobox protein 9 |
2560 |
0.22 |
chr19_44758783_44762005 | 7.68 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr6_28829740_28830660 | 7.62 |
Lrrc4 |
leucine rich repeat containing 4 |
145 |
0.96 |
chr11_21995570_21998947 | 7.55 |
Otx1 |
orthodenticle homeobox 1 |
4357 |
0.28 |
chr10_11080290_11081200 | 7.54 |
Grm1 |
glutamate receptor, metabotropic 1 |
211 |
0.95 |
chr7_126702563_126704731 | 7.51 |
Coro1a |
coronin, actin binding protein 1A |
473 |
0.55 |
chr13_55484574_55485692 | 7.45 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chr3_88214322_88216234 | 7.44 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr9_43746633_43747189 | 7.43 |
Gm30015 |
predicted gene, 30015 |
811 |
0.54 |
chr13_105444000_105445296 | 7.37 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr12_111668601_111669956 | 7.26 |
Ckb |
creatine kinase, brain |
2207 |
0.17 |
chr11_41999400_42000640 | 7.13 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr6_90809120_90810568 | 7.11 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
279 |
0.89 |
chr8_65617917_65619195 | 7.07 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
31 |
0.99 |
chr1_136132801_136134260 | 6.99 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chr4_140244024_140245271 | 6.97 |
Igsf21 |
immunoglobulin superfamily, member 21 |
2137 |
0.36 |
chr15_25713605_25714406 | 6.91 |
Myo10 |
myosin X |
134 |
0.97 |
chr2_71525880_71527745 | 6.91 |
Dlx1as |
distal-less homeobox 1, antisense |
1107 |
0.33 |
chr6_90781027_90782541 | 6.85 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr2_126552518_126553853 | 6.76 |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
405 |
0.86 |
chrX_105390628_105392456 | 6.74 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr5_75075112_75077490 | 6.67 |
Gsx2 |
GS homeobox 2 |
699 |
0.56 |
chr6_113890285_113891668 | 6.56 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
394 |
0.85 |
chr14_64588312_64589438 | 6.48 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr1_77505286_77506951 | 6.45 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chr2_157026864_157027931 | 6.40 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
75 |
0.96 |
chr9_21196536_21198489 | 6.34 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr3_108410436_108412210 | 6.33 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr14_67236008_67239452 | 6.32 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr6_119328752_119331284 | 6.28 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr7_45304558_45305606 | 6.26 |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
122 |
0.9 |
chr2_22623043_22623993 | 6.19 |
Gad2 |
glutamic acid decarboxylase 2 |
214 |
0.91 |
chr13_57907102_57908323 | 6.18 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
125 |
0.98 |
chr15_25754845_25755428 | 6.13 |
Myo10 |
myosin X |
2157 |
0.37 |
chr10_80154971_80156076 | 6.12 |
Midn |
midnolin |
4285 |
0.09 |
chr7_128689234_128689975 | 6.09 |
Gm43580 |
predicted gene 43580 |
1069 |
0.26 |
chr3_5222045_5223052 | 6.08 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chr9_58197310_58202560 | 6.07 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr9_10903843_10905236 | 6.07 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chr7_51623529_51624502 | 6.06 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr3_34656299_34657721 | 6.02 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
974 |
0.4 |
chrX_170674573_170675954 | 5.98 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr9_110726580_110727690 | 5.96 |
Myl3 |
myosin, light polypeptide 3 |
14726 |
0.1 |
chr4_15880938_15882113 | 5.94 |
Calb1 |
calbindin 1 |
259 |
0.9 |
chr8_83389618_83390628 | 5.92 |
Clgn |
calmegin |
245 |
0.9 |
chr15_91047599_91048010 | 5.91 |
Kif21a |
kinesin family member 21A |
2014 |
0.34 |
chr10_80298461_80300404 | 5.89 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr11_84520959_84524590 | 5.86 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr11_93098807_93100169 | 5.86 |
Car10 |
carbonic anhydrase 10 |
198 |
0.97 |
chr17_24240586_24240737 | 5.86 |
Ccnf |
cyclin F |
222 |
0.54 |
chr19_6501022_6501221 | 5.86 |
Nrxn2 |
neurexin II |
3286 |
0.16 |
chr7_51621596_51622924 | 5.85 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr8_94994139_94995207 | 5.81 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr6_101198088_101199306 | 5.81 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chr12_88724589_88725423 | 5.79 |
Nrxn3 |
neurexin III |
3 |
0.98 |
chr3_45379351_45381850 | 5.74 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr1_124045018_124046369 | 5.72 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr19_45230983_45235468 | 5.69 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr7_25290465_25291449 | 5.68 |
Cic |
capicua transcriptional repressor |
214 |
0.85 |
chr19_8838893_8839483 | 5.68 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chr3_68573207_68574269 | 5.68 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr11_61453075_61454398 | 5.67 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr4_150651111_150652374 | 5.65 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr7_16982884_16983633 | 5.62 |
Gm42372 |
predicted gene, 42372 |
172 |
0.9 |
chr7_61311164_61311772 | 5.61 |
A230006K03Rik |
RIKEN cDNA A230006K03 gene |
245 |
0.96 |
chr8_70533313_70533464 | 5.58 |
Fkbp8 |
FK506 binding protein 8 |
729 |
0.43 |
chr17_28040550_28042470 | 5.56 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr5_120430812_120431653 | 5.55 |
Lhx5 |
LIM homeobox protein 5 |
467 |
0.48 |
chr18_31446492_31447667 | 5.54 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr17_56241459_56242409 | 5.53 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chr18_82405647_82407688 | 5.52 |
Galr1 |
galanin receptor 1 |
110 |
0.96 |
chr7_79502506_79503035 | 5.52 |
Mir9-3 |
microRNA 9-3 |
2494 |
0.13 |
chr2_38354292_38355594 | 5.50 |
Lhx2 |
LIM homeobox protein 2 |
1141 |
0.41 |
chr7_79498955_79500626 | 5.46 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr7_121391567_121393161 | 5.45 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr14_66344363_66345813 | 5.44 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr2_158375202_158376961 | 5.42 |
Snhg11 |
small nucleolar RNA host gene 11 |
319 |
0.74 |
chr5_117841452_117842996 | 5.42 |
Nos1 |
nitric oxide synthase 1, neuronal |
38 |
0.98 |
chr2_158606690_158608449 | 5.41 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr5_111421306_111422790 | 5.39 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr19_60468285_60469063 | 5.38 |
Prlhr |
prolactin releasing hormone receptor |
370 |
0.9 |
chr7_79591572_79593069 | 5.38 |
Gm45169 |
predicted gene 45169 |
293 |
0.81 |
chr17_15370150_15371313 | 5.34 |
Dll1 |
delta like canonical Notch ligand 1 |
1100 |
0.46 |
chr14_54475593_54477091 | 5.32 |
Rem2 |
rad and gem related GTP binding protein 2 |
90 |
0.93 |
chr3_88211471_88212561 | 5.32 |
Gm3764 |
predicted gene 3764 |
2469 |
0.11 |
chr8_47283638_47284158 | 5.30 |
Stox2 |
storkhead box 2 |
5464 |
0.26 |
chr12_11881634_11882192 | 5.29 |
Tubb2a-ps2 |
tubulin, beta 2a, pseudogene 2 |
750 |
0.71 |
chr1_172056022_172057415 | 5.29 |
Nhlh1 |
nescient helix loop helix 1 |
855 |
0.45 |
chr5_106453173_106456366 | 5.28 |
Barhl2 |
BarH like homeobox 2 |
3397 |
0.22 |
chr11_119080607_119083001 | 5.28 |
Cbx4 |
chromobox 4 |
4417 |
0.17 |
chr4_115095506_115097361 | 5.24 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
5501 |
0.16 |
chr17_91093132_91093621 | 5.21 |
Nrxn1 |
neurexin I |
305 |
0.87 |
chr7_105568525_105569825 | 5.21 |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
90 |
0.94 |
chr8_70486586_70487634 | 5.20 |
Tmem59l |
transmembrane protein 59-like |
214 |
0.81 |
chr9_75683375_75684591 | 5.20 |
Scg3 |
secretogranin III |
8 |
0.97 |
chr2_114012816_114014272 | 5.18 |
A530058N18Rik |
RIKEN cDNA A530058N18 gene |
19 |
0.54 |
chr2_154634006_154634569 | 5.18 |
Gm14198 |
predicted gene 14198 |
1651 |
0.24 |
chr7_121393854_121394773 | 5.17 |
Gm36736 |
predicted gene, 36736 |
1212 |
0.44 |
chr2_25318080_25319601 | 5.17 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr13_54748886_54749162 | 5.17 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
645 |
0.59 |
chr19_6498687_6498960 | 5.15 |
Nrxn2 |
neurexin II |
988 |
0.42 |
chr4_32862939_32864770 | 5.11 |
Ankrd6 |
ankyrin repeat domain 6 |
3171 |
0.24 |
chr4_126465012_126466992 | 5.09 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr11_96279294_96280222 | 5.04 |
Hoxb8 |
homeobox B8 |
2147 |
0.12 |
chr11_69364290_69367679 | 5.03 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
1205 |
0.24 |
chr19_41742559_41744061 | 5.01 |
Slit1 |
slit guidance ligand 1 |
176 |
0.96 |
chr18_61737389_61738065 | 5.00 |
1500015A07Rik |
RIKEN cDNA 1500015A07 gene |
3370 |
0.17 |
chr2_158610228_158611991 | 4.99 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr2_26485135_26488628 | 4.99 |
Notch1 |
notch 1 |
16383 |
0.09 |
chr7_144285786_144285937 | 4.94 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
1316 |
0.55 |
chr8_106336310_106337932 | 4.94 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
chr10_116017652_116019652 | 4.93 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr5_90758918_90760166 | 4.93 |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
164 |
0.91 |
chr6_83185720_83187846 | 4.92 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr2_158614356_158617139 | 4.91 |
Gm14205 |
predicted gene 14205 |
3927 |
0.13 |
chr7_126950022_126951260 | 4.91 |
Sez6l2 |
seizure related 6 homolog like 2 |
57 |
0.89 |
chr11_69399334_69402458 | 4.91 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chr10_80270104_80272701 | 4.90 |
Dazap1 |
DAZ associated protein 1 |
6278 |
0.07 |
chr15_25754177_25754669 | 4.89 |
Myo10 |
myosin X |
1444 |
0.48 |
chr5_120431744_120433119 | 4.89 |
Gm27199 |
predicted gene 27199 |
664 |
0.41 |
chr11_102396401_102397380 | 4.88 |
Rundc3a |
RUN domain containing 3A |
974 |
0.35 |
chr1_135248312_135249161 | 4.86 |
Gm26642 |
predicted gene, 26642 |
175 |
0.91 |
chr13_69737356_69737994 | 4.85 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
2214 |
0.21 |
chr17_93198991_93201483 | 4.83 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr6_103510606_103512502 | 4.80 |
Chl1 |
cell adhesion molecule L1-like |
224 |
0.93 |
chr8_122480707_122480858 | 4.80 |
Ctu2 |
cytosolic thiouridylase subunit 2 |
140 |
0.89 |
chr10_79873254_79874939 | 4.79 |
Plppr3 |
phospholipid phosphatase related 3 |
128 |
0.72 |
chr5_137553079_137554278 | 4.79 |
Actl6b |
actin-like 6B |
121 |
0.89 |
chr15_77955664_77957039 | 4.77 |
Foxred2 |
FAD-dependent oxidoreductase domain containing 2 |
324 |
0.84 |
chr6_82403992_82404993 | 4.77 |
Tacr1 |
tachykinin receptor 1 |
1705 |
0.47 |
chr5_117415009_117415179 | 4.77 |
Ksr2 |
kinase suppressor of ras 2 |
1094 |
0.42 |
chr7_4119233_4120703 | 4.74 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr13_21896558_21897712 | 4.73 |
Mir1983 |
microRNA 1983 |
86 |
0.91 |
chr7_27354334_27354966 | 4.73 |
Shkbp1 |
Sh3kbp1 binding protein 1 |
1093 |
0.34 |
chr13_78194785_78195954 | 4.73 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1004 |
0.42 |
chr6_48537635_48538183 | 4.72 |
Atp6v0e2 |
ATPase, H+ transporting, lysosomal V0 subunit E2 |
244 |
0.61 |
chr5_98180058_98181966 | 4.72 |
Prdm8 |
PR domain containing 8 |
34 |
0.97 |
chr15_60822830_60824874 | 4.72 |
9930014A18Rik |
RIKEN cDNA 9930014A18 gene |
450 |
0.73 |
chr9_61376232_61377980 | 4.69 |
Tle3 |
transducin-like enhancer of split 3 |
1577 |
0.38 |
chr17_31295981_31297202 | 4.65 |
Gm8437 |
predicted gene 8437 |
98 |
0.67 |
chr14_55061871_55064122 | 4.64 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chrX_143666970_143667372 | 4.63 |
Pak3 |
p21 (RAC1) activated kinase 3 |
1426 |
0.57 |
chr1_154723254_154724531 | 4.63 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
2028 |
0.48 |
chr5_114570797_114571175 | 4.62 |
Fam222a |
family with sequence similarity 222, member A |
2969 |
0.22 |
chr17_56474107_56476457 | 4.60 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
655 |
0.65 |
chr5_138278831_138279972 | 4.60 |
Gm43720 |
predicted gene 43720 |
557 |
0.3 |
chr5_115433010_115433546 | 4.60 |
Msi1 |
musashi RNA-binding protein 1 |
114 |
0.91 |
chr9_108573133_108575666 | 4.60 |
Dalrd3 |
DALR anticodon binding domain containing 3 |
2007 |
0.1 |
chr11_120628644_120631479 | 4.59 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
87 |
0.89 |
chr14_25610327_25611867 | 4.59 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
3259 |
0.25 |
chrX_66655351_66656679 | 4.57 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
3008 |
0.24 |
chr14_121171778_121172858 | 4.56 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
70239 |
0.11 |
chr11_96987508_96988742 | 4.56 |
Sp2 |
Sp2 transcription factor |
5166 |
0.1 |
chr10_127167223_127168270 | 4.55 |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
1887 |
0.15 |
chr5_73189782_73190392 | 4.55 |
Gm42571 |
predicted gene 42571 |
330 |
0.81 |
chr7_131966504_131967699 | 4.54 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr16_18129524_18129878 | 4.52 |
Rtn4r |
reticulon 4 receptor |
2059 |
0.22 |
chr6_136170568_136170996 | 4.52 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr5_112225574_112226319 | 4.51 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
2695 |
0.17 |
chr4_9269280_9270516 | 4.51 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr10_80416971_80417651 | 4.50 |
Tcf3 |
transcription factor 3 |
1023 |
0.29 |
chr2_97468266_97469202 | 4.49 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chr9_44340460_44342952 | 4.48 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr8_108716860_108718878 | 4.48 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr11_120046152_120046417 | 4.48 |
Aatk |
apoptosis-associated tyrosine kinase |
786 |
0.45 |
chr19_46321973_46322685 | 4.48 |
Psd |
pleckstrin and Sec7 domain containing |
1730 |
0.17 |
chr12_16579767_16580202 | 4.46 |
Lpin1 |
lipin 1 |
9736 |
0.24 |
chr5_116589538_116590511 | 4.46 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr8_31915784_31916390 | 4.44 |
Nrg1 |
neuregulin 1 |
1563 |
0.42 |
chr2_180890379_180892235 | 4.42 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr3_17790150_17790808 | 4.41 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
522 |
0.77 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 22.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
4.7 | 14.2 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
4.7 | 14.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.1 | 12.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
3.4 | 10.3 | GO:0021586 | pons maturation(GO:0021586) |
3.2 | 25.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.2 | 22.2 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.1 | 9.3 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.9 | 8.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.7 | 5.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
2.5 | 7.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.5 | 5.0 | GO:0098597 | observational learning(GO:0098597) |
2.5 | 2.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.5 | 29.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
2.5 | 7.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
2.4 | 9.6 | GO:0046959 | habituation(GO:0046959) |
2.4 | 16.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.4 | 4.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.4 | 2.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.3 | 18.6 | GO:0071625 | vocalization behavior(GO:0071625) |
2.2 | 6.7 | GO:0015817 | histidine transport(GO:0015817) |
2.2 | 6.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.1 | 6.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 8.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.1 | 2.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
2.1 | 6.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.1 | 6.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.1 | 12.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.1 | 14.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.0 | 8.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.0 | 6.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.0 | 24.4 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
2.0 | 12.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.9 | 3.9 | GO:0046958 | nonassociative learning(GO:0046958) |
1.9 | 1.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.9 | 5.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.9 | 7.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.9 | 5.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.9 | 7.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.8 | 1.8 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.8 | 5.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.8 | 5.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.7 | 7.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.7 | 5.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.7 | 3.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.7 | 1.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.7 | 5.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.7 | 5.0 | GO:0060066 | oviduct development(GO:0060066) |
1.7 | 5.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.6 | 4.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.6 | 3.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.6 | 1.6 | GO:0045632 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
1.6 | 11.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.6 | 12.7 | GO:0060013 | righting reflex(GO:0060013) |
1.6 | 6.3 | GO:0060594 | mammary gland specification(GO:0060594) |
1.5 | 12.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.5 | 4.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 12.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.5 | 7.4 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.5 | 5.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.5 | 4.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.5 | 4.4 | GO:0035106 | operant conditioning(GO:0035106) |
1.5 | 5.9 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
1.5 | 10.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.5 | 2.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.4 | 2.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.4 | 2.9 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.4 | 1.4 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.4 | 24.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.4 | 4.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.4 | 4.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.4 | 5.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.4 | 4.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.4 | 6.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.4 | 9.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.4 | 6.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.4 | 4.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.4 | 6.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.4 | 5.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.4 | 6.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.3 | 5.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.3 | 1.3 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
1.3 | 6.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.3 | 1.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.3 | 1.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.3 | 1.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.3 | 2.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.3 | 6.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.2 | 1.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.2 | 2.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.2 | 3.7 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.2 | 17.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
1.2 | 3.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.2 | 3.7 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.2 | 3.7 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 3.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.2 | 3.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.2 | 3.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.2 | 4.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.2 | 2.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.2 | 1.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.2 | 3.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.2 | 2.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.2 | 4.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.2 | 3.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.2 | 17.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.2 | 3.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.2 | 20.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.2 | 3.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.1 | 1.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.1 | 3.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.1 | 1.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.1 | 3.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.1 | 1.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.1 | 3.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.1 | 4.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.1 | 3.3 | GO:0000087 | mitotic M phase(GO:0000087) |
1.1 | 14.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
1.1 | 3.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 3.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
1.1 | 2.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
1.1 | 2.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.1 | 7.5 | GO:0015684 | ferrous iron transport(GO:0015684) |
1.1 | 1.1 | GO:1901656 | glycoside transport(GO:1901656) |
1.1 | 3.2 | GO:0070268 | cornification(GO:0070268) |
1.1 | 2.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.1 | 6.3 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.1 | 3.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.0 | 4.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 3.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.0 | 4.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 1.0 | GO:0072289 | ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
1.0 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.0 | 1.0 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.0 | 20.5 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
1.0 | 5.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 15.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 7.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.0 | 4.0 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.0 | 3.0 | GO:0040031 | snRNA modification(GO:0040031) |
1.0 | 16.0 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.0 | 3.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.0 | 6.0 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.0 | 7.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.0 | 3.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.0 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.0 | 3.0 | GO:0006562 | proline catabolic process(GO:0006562) |
1.0 | 3.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.0 | 2.9 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
1.0 | 2.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 2.9 | GO:1902075 | cellular response to salt(GO:1902075) |
1.0 | 3.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.0 | 22.0 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
1.0 | 2.9 | GO:0002254 | kinin cascade(GO:0002254) |
1.0 | 2.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 4.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.0 | 2.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.9 | 5.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.9 | 2.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.9 | 3.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.9 | 6.6 | GO:0002576 | platelet degranulation(GO:0002576) |
0.9 | 4.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.9 | 7.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 2.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.9 | 1.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 2.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.9 | 5.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.9 | 1.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.9 | 4.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.9 | 3.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.9 | 1.8 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.9 | 8.9 | GO:0015816 | glycine transport(GO:0015816) |
0.9 | 1.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.9 | 5.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.9 | 3.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.9 | 2.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.9 | 1.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 12.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.9 | 3.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.9 | 4.4 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.9 | 1.8 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 1.7 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 2.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 1.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.9 | 13.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 4.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.9 | 5.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.9 | 7.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 1.7 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.9 | 1.7 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.9 | 3.4 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.9 | 3.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 3.4 | GO:0030432 | peristalsis(GO:0030432) |
0.9 | 2.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.9 | 2.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.9 | 3.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.9 | 0.9 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.8 | 2.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 5.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.8 | 3.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.8 | 2.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.8 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 2.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.8 | 0.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.8 | 7.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.8 | 0.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.8 | 3.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.8 | 4.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.8 | 3.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.8 | 17.1 | GO:0007616 | long-term memory(GO:0007616) |
0.8 | 4.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.8 | 1.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.8 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 4.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 1.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.8 | 1.6 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 1.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 1.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.8 | 3.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.8 | 3.2 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.8 | 1.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.8 | 3.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 1.6 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.8 | 0.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 2.4 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.8 | 2.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.8 | 0.8 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.8 | 0.8 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.8 | 2.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 1.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.8 | 2.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 0.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.8 | 9.4 | GO:0035640 | exploration behavior(GO:0035640) |
0.8 | 3.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.8 | 2.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.8 | 5.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 6.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.8 | 0.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 3.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 3.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 19.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.8 | 1.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.8 | 2.3 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.8 | 6.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.8 | 3.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.8 | 3.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.8 | 6.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.8 | 4.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 0.8 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.8 | 1.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.8 | 1.5 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.8 | 3.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 3.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.8 | 12.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 4.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.8 | 2.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.8 | 4.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.7 | 3.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 5.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 1.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 5.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 2.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.7 | 37.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 5.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.7 | 3.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.7 | 5.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 7.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.7 | 2.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.7 | 1.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 1.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 1.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 3.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.7 | 2.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.7 | 10.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.7 | 1.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.7 | 3.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 2.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.7 | 3.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 2.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.7 | 0.7 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.7 | 2.1 | GO:0015747 | urate transport(GO:0015747) |
0.7 | 2.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.7 | 3.5 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.7 | 3.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.7 | 2.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.7 | 2.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 1.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 9.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.7 | 2.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 5.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.7 | 1.4 | GO:0009629 | response to gravity(GO:0009629) |
0.7 | 2.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.7 | 1.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 6.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.7 | 2.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 8.9 | GO:0001964 | startle response(GO:0001964) |
0.7 | 2.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 3.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 2.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 2.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 7.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.7 | 3.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 5.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 5.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 3.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 4.0 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.7 | 1.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.7 | 2.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.7 | 3.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.7 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 1.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.7 | 6.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.7 | 3.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.7 | 2.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.6 | 3.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.6 | 0.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 18.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.6 | 1.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.6 | 1.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 4.5 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.6 | 1.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.6 | 1.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.6 | 3.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.6 | 2.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.6 | 3.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 2.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.6 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.6 | 3.7 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 3.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.6 | 2.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 1.8 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.6 | 6.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.6 | 1.2 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.6 | 1.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 2.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.6 | 2.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.6 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 3.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.6 | 4.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.6 | 1.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 1.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 1.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.6 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.6 | 9.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.6 | 5.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.6 | 2.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 2.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.6 | 2.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 3.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 1.8 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.6 | 3.5 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.6 | 0.6 | GO:0015677 | copper ion import(GO:0015677) |
0.6 | 3.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 2.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 3.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 1.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 0.6 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.6 | 0.6 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 1.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.6 | 5.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.6 | 2.3 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.6 | 2.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 1.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.6 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 1.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 1.7 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.6 | 1.7 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.6 | 4.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 1.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.6 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 2.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 5.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 1.7 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.6 | 1.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 3.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.6 | 5.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.6 | 10.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 2.2 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.6 | 5.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.6 | 0.6 | GO:0043307 | eosinophil activation(GO:0043307) |
0.6 | 2.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 1.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 1.6 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.5 | 2.7 | GO:0015840 | urea transport(GO:0015840) |
0.5 | 1.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 5.4 | GO:0034311 | diol metabolic process(GO:0034311) |
0.5 | 2.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.5 | 2.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.5 | 1.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 0.5 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.5 | 2.2 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.5 | 3.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.5 | 1.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 3.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 2.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 3.2 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.5 | 1.6 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.5 | 1.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.5 | 1.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.5 | 1.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.5 | 1.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 14.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 1.1 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.5 | 4.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.5 | 1.6 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 2.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.5 | 2.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 4.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 2.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 1.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.5 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 5.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.5 | 1.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 2.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 1.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 1.0 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.5 | 1.0 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.5 | 1.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 1.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 1.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.5 | 15.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.5 | 1.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 1.0 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.5 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 2.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 1.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.5 | 2.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.5 | 3.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 2.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 4.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 10.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.5 | 4.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 1.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 1.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.5 | 2.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 2.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 2.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.5 | 5.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.5 | 3.8 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.5 | 1.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.5 | 1.0 | GO:0032782 | bile acid secretion(GO:0032782) |
0.5 | 1.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 9.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 1.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 0.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.5 | 2.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 4.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 5.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 1.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 5.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 0.5 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.5 | 4.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.5 | 2.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 3.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 5.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 2.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 0.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.5 | 2.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.5 | 1.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 1.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 0.9 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 2.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 1.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 0.9 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 0.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.4 | 7.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.4 | 1.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 3.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.4 | 2.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 3.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 1.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 0.4 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.4 | 0.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 3.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.4 | 0.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 2.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 1.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 0.4 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.4 | 0.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 1.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 0.9 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 1.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.4 | 26.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 2.5 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.4 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.4 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 0.8 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 0.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 0.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 2.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 2.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 0.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 0.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 0.8 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.4 | 2.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 3.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.4 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.4 | 1.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 0.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 0.4 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.4 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 2.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 2.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.8 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.4 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.4 | 0.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 2.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.4 | 0.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.4 | 1.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.4 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 0.8 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.4 | 5.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 22.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 2.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 4.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 3.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 0.8 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.4 | 1.2 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.4 | 3.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 2.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.4 | 0.4 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.4 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 5.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.4 | 0.8 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 1.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.4 | 1.6 | GO:0010458 | exit from mitosis(GO:0010458) |
0.4 | 0.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.4 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 4.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.4 | 1.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.4 | 1.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 1.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 2.7 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 1.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.4 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 6.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 1.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.4 | 1.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 1.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.4 | 1.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 1.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 1.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.4 | 1.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 0.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 1.5 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.4 | 1.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.8 | GO:0006560 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.4 | 1.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 0.4 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.4 | 1.8 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.4 | 2.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 0.7 | GO:0072017 | distal tubule development(GO:0072017) |
0.4 | 1.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.4 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.4 | 3.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 7.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 1.8 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 0.7 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 3.2 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.4 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.4 | 1.4 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.4 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 1.4 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 1.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 1.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.4 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 1.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 1.0 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.7 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 0.7 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.3 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.3 | 0.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 2.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 1.4 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.3 | 2.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 2.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.3 | 2.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 2.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 2.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 2.0 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.3 | 6.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.0 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 1.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 3.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 1.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 3.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 1.9 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 2.2 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.3 | 0.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.3 | 1.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 12.5 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 3.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 4.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 3.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.3 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 3.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 0.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.3 | 1.6 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 1.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.3 | 6.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 3.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.3 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 1.6 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
0.3 | 0.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 4.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 0.6 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.3 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 0.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 1.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 3.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.3 | 1.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 1.8 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 2.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 1.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 2.1 | GO:0019068 | virion assembly(GO:0019068) |
0.3 | 10.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.6 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.3 | 1.2 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 0.6 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 2.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 10.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.3 | GO:0010520 | meiotic gene conversion(GO:0006311) regulation of reciprocal meiotic recombination(GO:0010520) gene conversion(GO:0035822) |
0.3 | 2.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 1.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 0.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 7.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 2.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 6.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 3.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 1.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 3.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.3 | 0.3 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.3 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.8 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 0.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 1.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.3 | GO:0045054 | multivesicular body organization(GO:0036257) constitutive secretory pathway(GO:0045054) |
0.3 | 8.1 | GO:0036503 | ERAD pathway(GO:0036503) |
0.3 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 1.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 1.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 1.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.3 | 3.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.8 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 1.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 0.8 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 0.5 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 1.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 5.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 7.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 1.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 0.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.5 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.3 | 0.8 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 1.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 0.5 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.3 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 1.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 13.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.3 | 0.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.3 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 5.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 0.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 2.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 3.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 3.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 5.1 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 0.8 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.8 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 16.9 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 1.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 2.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.2 | 1.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 2.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 1.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 2.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 5.8 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 6.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 7.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 2.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 0.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.5 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 2.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 2.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 6.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 2.9 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 1.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 0.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.7 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 2.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 2.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.2 | 2.6 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.6 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.6 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 1.9 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.9 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.4 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 1.9 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 1.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 4.9 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.2 | 3.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 1.0 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 1.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 2.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.4 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 1.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.8 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.2 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 1.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 3.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 1.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 5.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.4 | GO:0043144 | snoRNA processing(GO:0043144) |
0.2 | 1.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 2.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.2 | 0.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 6.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 11.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 5.7 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 2.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 1.6 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.2 | 1.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.2 | 2.7 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 1.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.8 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 1.0 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 2.9 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 1.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.2 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 5.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 1.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.7 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.2 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.4 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 1.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 6.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.9 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 1.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 2.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 3.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 1.9 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 0.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.2 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.2 | 1.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.9 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 2.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 4.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 1.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 2.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 10.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.3 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.2 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.8 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 0.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.2 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.2 | 1.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.2 | 4.9 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 0.3 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.2 | 1.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.2 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.2 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.5 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.3 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 1.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.6 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.5 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.2 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.2 | GO:0070723 | response to cholesterol(GO:0070723) |
0.2 | 0.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 3.3 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 1.2 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.1 | 0.3 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.1 | 0.6 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 1.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 1.8 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
0.1 | 0.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.9 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 2.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 1.9 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.3 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.8 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 1.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 4.2 | GO:0072376 | protein activation cascade(GO:0072376) |
0.1 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 1.2 | GO:0099587 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.1 | 2.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.3 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 1.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.1 | GO:0070668 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 1.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.1 | 0.3 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.4 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 1.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 1.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.4 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.5 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.4 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 1.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 5.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 3.0 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 1.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.5 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.7 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 1.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 1.0 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.1 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.2 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 2.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.6 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 2.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.6 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 2.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.4 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 1.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 3.4 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 3.2 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.2 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 2.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.6 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.1 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0032645 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.1 | 1.0 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 1.3 | GO:0007269 | neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
0.1 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.3 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 1.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.2 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 4.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 3.6 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.3 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 1.2 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 1.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.5 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.0 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.0 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
5.3 | 15.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.7 | 16.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.3 | 4.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.2 | 8.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.1 | 40.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.1 | 16.6 | GO:0043083 | synaptic cleft(GO:0043083) |
2.0 | 2.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.9 | 9.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 3.7 | GO:0044393 | microspike(GO:0044393) |
1.8 | 12.6 | GO:0032584 | growth cone membrane(GO:0032584) |
1.7 | 13.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.7 | 6.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.7 | 6.7 | GO:0044308 | axonal spine(GO:0044308) |
1.5 | 4.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.5 | 4.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.5 | 5.9 | GO:0043194 | axon initial segment(GO:0043194) |
1.5 | 1.5 | GO:0031143 | pseudopodium(GO:0031143) |
1.4 | 10.1 | GO:0097449 | astrocyte projection(GO:0097449) |
1.4 | 12.9 | GO:0005883 | neurofilament(GO:0005883) |
1.4 | 4.3 | GO:1990635 | proximal dendrite(GO:1990635) |
1.4 | 19.9 | GO:0071565 | nBAF complex(GO:0071565) |
1.3 | 5.3 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 3.9 | GO:0072534 | perineuronal net(GO:0072534) |
1.3 | 13.8 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 16.1 | GO:0033268 | node of Ranvier(GO:0033268) |
1.2 | 3.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.2 | 4.8 | GO:0071797 | LUBAC complex(GO:0071797) |
1.2 | 3.5 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 59.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
1.1 | 3.4 | GO:0070552 | BRISC complex(GO:0070552) |
1.1 | 3.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.1 | 29.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.1 | 4.3 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 36.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.0 | 2.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.0 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.0 | 10.8 | GO:0035102 | PRC1 complex(GO:0035102) |
1.0 | 1.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.0 | 6.8 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 6.7 | GO:0005688 | U6 snRNP(GO:0005688) |
1.0 | 5.8 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 3.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 5.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.9 | 2.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.9 | 6.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.9 | 4.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.9 | 6.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 5.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 6.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.8 | 3.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.8 | 4.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.8 | 2.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 2.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 2.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 18.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.8 | 3.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.8 | 3.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 1.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 6.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 16.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.7 | 1.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.7 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 10.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 1.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 2.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 1.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.7 | 2.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 2.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 2.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 4.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.7 | 4.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 7.6 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 3.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 4.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 2.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 9.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.7 | 6.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.7 | 3.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.7 | 2.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 2.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 5.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 3.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.7 | 5.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.7 | 3.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 5.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 14.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.6 | 2.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 18.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 11.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 2.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 5.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 6.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 7.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 1.8 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 10.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.6 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 4.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 4.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 7.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 5.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.6 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.6 | 5.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 2.3 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 1.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 3.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 3.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.5 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 3.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.5 | 2.6 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 1.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 2.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 6.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 3.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 7.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.5 | 2.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 6.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 2.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.5 | 2.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 2.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 5.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 3.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 4.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 4.7 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 1.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 0.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 1.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 13.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 2.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 1.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 2.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 4.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.3 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 1.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 1.3 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 37.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 4.4 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 58.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 0.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 1.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 0.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 2.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 2.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 6.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 1.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 6.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 4.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.4 | 2.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.4 | 4.5 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 3.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 0.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 3.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 3.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 1.6 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 26.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.4 | 2.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 3.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 8.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 2.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 2.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.4 | 6.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 3.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 1.9 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 15.4 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 0.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 2.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 10.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 3.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 1.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 1.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 2.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 0.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.4 | 16.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 119.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 2.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 2.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 4.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 5.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 0.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 3.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 5.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 2.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 3.7 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 20.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 3.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 2.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 12.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 5.6 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 2.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 3.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.8 | GO:0061702 | inflammasome complex(GO:0061702) |
0.3 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 11.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 10.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 5.7 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.3 | 3.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 4.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 7.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 10.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.3 | 3.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.3 | 1.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.3 | 2.3 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 3.4 | GO:0001741 | XY body(GO:0001741) |
0.3 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 2.2 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 13.2 | GO:0044297 | cell body(GO:0044297) |
0.3 | 0.8 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 23.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 3.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 14.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.3 | 0.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 2.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 1.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 19.4 | GO:0030424 | axon(GO:0030424) |
0.3 | 8.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 3.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 2.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 13.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 8.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.8 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 1.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 3.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 2.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 2.6 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 2.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 2.8 | GO:0005844 | polysome(GO:0005844) |
0.2 | 23.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 3.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 4.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.1 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 2.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 5.4 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 2.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.7 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 4.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 6.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 2.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 9.8 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.7 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 2.7 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 2.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 2.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.2 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 2.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 4.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 3.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 2.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 2.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 3.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 1.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 22.5 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 3.8 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 0.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 2.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 6.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.8 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.0 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 1.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 39.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 12.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.8 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 2.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.1 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 1.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 31.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 3.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 7.5 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 33.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 5.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 7.0 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 52.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 6.6 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 3.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 4.9 | GO:0031975 | envelope(GO:0031975) |
0.1 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 51.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 191.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 144.0 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 3.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 17.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
4.2 | 4.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.0 | 11.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.4 | 30.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.3 | 9.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.0 | 9.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.5 | 7.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.3 | 18.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.2 | 6.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.1 | 10.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 5.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.9 | 9.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.9 | 13.4 | GO:0030957 | Tat protein binding(GO:0030957) |
1.9 | 7.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.9 | 5.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.8 | 14.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.7 | 7.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.7 | 8.7 | GO:0005499 | vitamin D binding(GO:0005499) |
1.7 | 5.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.7 | 18.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.7 | 6.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.6 | 17.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.6 | 6.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.5 | 6.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 6.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.5 | 4.5 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.4 | 4.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.4 | 5.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.4 | 9.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.3 | 14.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.3 | 3.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.3 | 6.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.3 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.3 | 16.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.2 | 6.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.2 | 3.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.2 | 3.7 | GO:0042731 | PH domain binding(GO:0042731) |
1.2 | 3.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.2 | 4.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 2.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
1.2 | 10.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 4.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.2 | 3.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 5.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.2 | 2.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.1 | 4.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.1 | 1.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.1 | 35.0 | GO:0030507 | spectrin binding(GO:0030507) |
1.1 | 1.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.1 | 3.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.1 | 7.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 1.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
1.1 | 6.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 6.5 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 3.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.1 | 15.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 2.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.0 | 2.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 3.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.0 | 5.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.0 | 3.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.0 | 7.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.0 | 7.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.0 | 2.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.0 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.0 | 9.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.0 | 5.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.0 | 6.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.0 | 5.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.0 | 2.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.0 | 1.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.0 | 2.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.0 | 3.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.0 | 2.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.0 | 3.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.0 | 21.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 7.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.9 | 11.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.9 | 0.9 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.9 | 3.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.9 | 10.2 | GO:0043176 | amine binding(GO:0043176) |
0.9 | 4.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.9 | 7.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 3.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.9 | 2.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.9 | 3.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.9 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 4.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.9 | 8.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 2.7 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 2.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.9 | 11.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 5.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.9 | 14.3 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.9 | 3.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 0.9 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.9 | 2.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.9 | 6.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.9 | 2.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.9 | 0.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.9 | 5.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 3.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.8 | 1.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.8 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 2.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 1.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.8 | 2.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 4.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 1.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 10.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.8 | 4.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.8 | 8.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 2.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 11.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.8 | 2.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 5.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 2.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 3.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.8 | 0.8 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.8 | 14.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.8 | 0.8 | GO:0043398 | HLH domain binding(GO:0043398) |
0.8 | 6.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 1.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 3.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 2.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 2.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 3.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 2.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.8 | 4.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 15.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 6.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 3.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 5.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.7 | 11.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 5.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 5.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 2.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.7 | 3.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 4.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 4.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.7 | 7.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.7 | 3.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.7 | 1.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 1.4 | GO:0033265 | choline binding(GO:0033265) |
0.7 | 2.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.7 | 3.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 7.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 2.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.7 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 1.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 6.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.7 | 12.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.7 | 3.3 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 0.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.7 | 2.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 5.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 2.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.7 | 7.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 5.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 2.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 1.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.6 | 14.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 5.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.6 | 10.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.6 | 2.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 14.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 1.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 1.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 8.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.6 | 2.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.6 | 1.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 3.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 1.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 3.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 1.8 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 8.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.6 | 6.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.6 | 1.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 5.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 3.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.6 | 3.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 4.7 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 10.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.6 | 1.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 1.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.6 | 1.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 1.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 1.2 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 3.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 1.7 | GO:0034925 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.6 | 2.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 2.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.6 | 0.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 3.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.6 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.6 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 1.7 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.6 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) steroid hormone binding(GO:1990239) |
0.6 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.6 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 1.7 | GO:0032564 | dATP binding(GO:0032564) |
0.6 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 3.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 2.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 1.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 13.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 4.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 7.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 4.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 2.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 2.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 1.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 2.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 1.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 3.2 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 1.6 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 2.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 5.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 1.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 1.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 6.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 8.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 2.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 8.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 3.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.5 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.5 | 1.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.5 | 2.0 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 1.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 2.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 2.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 1.5 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 5.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 1.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.5 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 2.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 9.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 1.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 8.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 4.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 1.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.5 | 2.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 2.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 0.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 3.2 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 7.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 2.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 5.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 1.8 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.4 | 4.9 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 4.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 0.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.4 | 14.9 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.4 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 3.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 2.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 1.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.4 | 1.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 9.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 1.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.4 | 2.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 3.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 9.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 3.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 1.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 2.0 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 2.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 4.8 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 2.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 1.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 1.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 7.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.4 | 2.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 3.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 19.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.4 | 5.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 3.0 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 11.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 2.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 0.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.4 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 0.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 1.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 2.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 15.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 2.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 10.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.4 | 1.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 0.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.4 | 1.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 12.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 19.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 1.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.3 | 1.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 0.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 8.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 1.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 1.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 2.0 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 6.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 1.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 7.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 7.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 3.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 1.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 2.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 1.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 5.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 3.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 1.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 4.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 1.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.3 | 1.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 2.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 3.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 7.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 2.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 0.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 3.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 0.6 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 2.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 2.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 0.3 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.3 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 0.9 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.3 | 1.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.3 | 0.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 1.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 0.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.3 | 1.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 1.5 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 5.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 6.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 2.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 6.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 0.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 41.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 14.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 3.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.3 | 1.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 0.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 21.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 5.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 3.0 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.3 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 2.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 4.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 0.8 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 12.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 0.8 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 1.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 2.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 0.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.3 | 3.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 2.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 1.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 6.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 3.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.2 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 4.6 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 4.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 3.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 3.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.2 | 2.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.9 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 5.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 1.6 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 1.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.7 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.2 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 3.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 5.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 1.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 38.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 3.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.8 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 7.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 4.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 40.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 2.5 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 18.1 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 1.0 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 10.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 2.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 1.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 3.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.2 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 5.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 4.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 18.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 1.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 5.2 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 2.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 3.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 1.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 4.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.2 | 1.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 2.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 3.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 9.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 4.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 2.7 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.5 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 6.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 4.5 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 2.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 3.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.6 | GO:0070990 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 8.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 8.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 9.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 4.9 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 3.5 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.5 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 4.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 2.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 3.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 5.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.2 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 3.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 5.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 1.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 2.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 9.7 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 3.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 3.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 3.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 1.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 3.5 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 97.4 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.1 | GO:0030553 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cGMP binding(GO:0030553) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 5.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 0.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 1.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 36.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 1.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 1.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 1.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 1.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 2.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.0 | 2.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 18.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.6 | 4.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 19.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 9.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 25.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 17.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.6 | 12.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 13.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 16.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 4.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 10.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 7.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 6.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 17.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 11.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 3.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 4.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 10.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 10.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 10.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 16.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 4.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 8.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 3.2 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 5.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 5.9 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 3.3 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 2.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 4.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 8.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 4.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 1.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 4.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 5.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 5.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
2.4 | 40.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.8 | 24.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.4 | 21.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 16.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 13.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 4.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.0 | 10.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.0 | 4.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.0 | 9.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 10.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 3.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.0 | 6.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.9 | 5.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.9 | 5.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 9.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.9 | 8.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 7.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.8 | 9.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.8 | 8.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 2.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.7 | 8.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.7 | 11.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 11.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.7 | 33.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.7 | 6.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.7 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 5.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 18.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 5.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 10.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 19.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 6.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 12.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 5.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 13.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 12.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 2.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 7.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.6 | 3.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 6.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 2.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 5.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 10.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 7.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.5 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 7.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 0.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 3.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 2.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 5.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 6.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 2.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 4.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.5 | 8.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 4.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 1.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 34.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 2.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 6.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 8.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.4 | 12.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 17.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.4 | 2.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 5.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 3.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 4.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 4.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 3.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 5.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.4 | 2.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 6.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 3.9 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.4 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 3.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 15.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 3.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 4.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 5.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 4.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 2.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 0.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.3 | 4.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 2.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 11.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 47.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 3.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 0.8 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.3 | 4.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 3.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 6.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 7.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.3 | 14.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 3.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 21.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 1.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 5.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 1.5 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 10.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 2.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 3.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 5.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.4 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.2 | 1.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 1.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 5.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 4.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 4.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 9.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 6.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 2.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 0.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 1.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 15.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 0.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 4.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 2.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 1.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 2.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 6.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.2 | 1.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 6.2 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.2 | 0.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 3.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 5.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 0.8 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 0.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 1.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.5 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 4.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 3.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 4.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 5.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 4.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 2.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.4 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 4.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 5.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.5 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.8 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |